Maria G. Vitale

Modena, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Corrigendum to "Efficacy and Safety Outcomes of Stereotactic Radiotherapy with Cyberknife System in Brain Metastases patients treated with Immunotherapy (IO) or Targeted Therapy (TT)" [Clin Oncol 52C (2026) 104084].

Corrigendum to "Efficacy and Safety Outcomes of Stereotactic Radiotherapy with Cyberknife System in Brain Metastases patients treated with Immunotherapy (IO) or Targeted Therapy (TT)" [Clin Oncol 52C (2026) 104084].

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: May 07, 2026

Enterotype-specific microbial biomarkers of immune checkpoint inhibitor response revealed by large-scale integrated metagenomic analysis.

Enterotype-specific microbial biomarkers of immune checkpoint inhibitor response revealed by large-scale integrated metagenomic analysis.

Journal: Cancer immunology, immunotherapy : CII

Published: April 08, 2026

Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33-REGAL study.

Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33-REGAL study.

Journal: Therapeutic advances in medical oncology

Published: January 26, 2026

Future directions for antibody-drug conjugates in urothelial cancer.

Future directions for antibody-drug conjugates in urothelial cancer.

Journal: Expert review of anticancer therapy

Published: November 20, 2025

Molecular Landscape of Advanced Endometrial Cancer: Exploratory Analyses at Modena Cancer Center (MEMO).

Molecular Landscape of Advanced Endometrial Cancer: Exploratory Analyses at Modena Cancer Center (MEMO).

Journal: International journal of molecular sciences

Published: November 11, 2025

Long-Term Oncological Outcomes in Metastatic Prostate Cancer Patients Who Are Able to Maintain/Recover Ongoing Anticancer Therapy After SARS-CoV-2 Infection-Results of the MEET-URO 22 Study.

Long-Term Oncological Outcomes in Metastatic Prostate Cancer Patients Who Are Able to Maintain/Recover Ongoing Anticancer Therapy After SARS-CoV-2 Infection-Results of the MEET-URO 22 Study.

Journal: Cancers

Published: October 26, 2025

Efficacy and Safety Outcomes of Stereotactic Radiotherapy With Cyberknife System in Brain Metastases Patients Treated With Immunotherapy or Targeted Therapy.

Efficacy and Safety Outcomes of Stereotactic Radiotherapy With Cyberknife System in Brain Metastases Patients Treated With Immunotherapy or Targeted Therapy.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: January 27, 2025

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 26, 2024

Extravasation of enfortumab vedotin: a case report and literature review on antibody-drug conjugates.

Extravasation of enfortumab vedotin: a case report and literature review on antibody-drug conjugates.

Journal: European journal of hospital pharmacy : science and practice

Published: August 29, 2024

New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives.

New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives.

Journal: International journal of molecular sciences

Published: August 07, 2024

A Novel Molecular Profile of Hormone-Sensitive Prostate Cancer Defines High Risk Patients.

A Novel Molecular Profile of Hormone-Sensitive Prostate Cancer Defines High Risk Patients.

Journal: Cancer medicine

Published: July 08, 2024

Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).

Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).

Journal: Targeted oncology

Published: April 11, 2024

Showing 1-12 of 72

Last Updated: 09/26/2026